Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Laminar Medica Ltd

    Laminar Medica specialises in the design, test, manufacture and qualification of insulated shipping systems, used by the pharmaceutical and biotech industries globally. These systems protect vaccines, drugs, blood and associated medical products from extremes of temperature during transportation.

    This is a FREE LISTING on PMHUB

    Below are full profiles from other companies in related areas

    No items found

    Company Details

    Laminar Medica Ltd
    Unit 4, Tring Industrial Estate Icknield Way, Tring, Hertfordshire, HP23 4JX, United Kingdom
    +44 (0)1442 828664
    Contact Laminar Medica Ltd
    Website

     Latest Content from PMHub 

    Pharma need to keep their ‘pull & push’ separate from their ‘inbound & outbound’

    White Papers and Resources | August 8, 2017 | An agency called Owen

    Is your pharma brand using the marketing terms ‘pull & push’ correctly?

    A man walks into a surgery: The role of storytelling in pharma marketing

    White Papers and Resources | August 4, 2017 | Life Healthcare Communications

    Communicating through stories can make your brand messages more meaningful, memorable and persuasive

    Embracing the demands of the empowered ‘consumer-savvy’ patient by Ann Generlich

    White Papers and Resources | August 3, 2017 | Say Communications

    Our access to information, which is now constantly at our fingertips and the explosion of new technologies has shifted the buying power to increasingly ‘consumer-savvy’ patients. These are patients who choose...

    The Art of Agile Marketing

    White Papers and Resources | August 3, 2017 | Anthill Agency

    The industry knows that it needs become more responsive to its stakeholders. An agile approach – which quickly improves results through a process of rapid market feedback and response –...

    Could ketamine be the next big thing in depression?

    White Papers and Resources | August 3, 2017 | Blue Latitude Health

    Account Executive Will Frostick discusses the established treatment model for depression and its limitations, as well as a new entrant poised to revolutionise the field – ketamine.

    Attracting doctors to low-demand specialties: A role for industry?

    White Papers and Resources | August 3, 2017 | Porterhouse Medical Group

     One of the major problems that healthcare systems around the world face is a paucity of medically qualified staff entering particular specialties and subspecialties. This can be due to a...

    Men vs Women in emerging markets

    White Papers and Resources | August 2, 2017 | Inizio

    Our latest interactive infographic compares male vs female health characteristics in the BRIC emerging marketS

    South Korea: The next global player?

    White Papers and Resources | August 2, 2017 | Inizio

    In this paper, we will explore some of the key trends and outlooks for South Korea in more detail, including what lies behind its presence at the extremes of two...

    20 questions: Round 4

    White Papers and Resources | August 2, 2017 | Inizio

    As it's our 20th year anniversary, we invited our employees to play our version of 20 questions - this month "What’s been the funniest thing to happen to you whilst you’ve...

    Will gene therapies finally be commercially viable to pharma?

    White Papers and Resources | August 2, 2017 | Inizio

    Our latest Free Thinking white paper explores the science behind the idea of gene therapy and takes a look at some of the core challenges medical researchers have faced when...